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Abstract
Background: Breast cancer patients are increasingly seeking Complementary and Alternative Medicine (CAM)
therapies with the hope of alleviating the burden of the disease and improving their quality of life (QOL). The
objective of this study was to assess the prevalence, types, socio-demographic and disease-related correlates as well
as characteristics of CAM use (including disclosure to treating physicians) among breast cancer patients in Beirut,
Lebanon. A secondary objective was to evaluate the association between CAM use and QOL.
Methods: A cross-sectional survey was conducted on breast cancer patients recruited from two major referral
centers in Beirut: a philanthropic hospital and a private academic medical center. In face-to-face interviews,
participants completed a questionnaire of three sections: socio-demographic and lifestyle characteristics, breast
cancer condition, and CAM use. Three to four weeks following these interviews, the secondary QOL assessment
was carried out via telephone using the Arabic version of the Functional Assessment of Cancer Therapy-Breast
questionnaire. The main outcome in this study, CAM use, was defined as using CAM at least once after breast
cancer diagnosis.
Results: A total of 180 breast cancer patients completed the survey (response rate: 94.6 %). Prevalence of CAM use
was 40 %. Using multivariate logistic regression, CAM use was negatively associated with age (OR: 0.96, CI: 0.92-0.99),
treatment at the philanthropic hospital (OR: 0.13, CI: 0.05-0.35) and was positively associated with an advanced stage of
the disease (OR: 4.20, CI: 1.65-10.69). Among study participants recruited from both sites, the most commonly used
CAM was ‘special food’ followed by ‘herbal teas’ , ‘diet supplements’ and ‘Spiritual healing’. Only 4 % of CAM users cited
health professionals as influencing their choice of CAM and only one in four patients disclosed CAM use to their
treating physician. There was no significant association between CAM use and QOL.
Conclusions: The findings of this study revealed a prevalent CAM use among Lebanese breast cancer patients.
Furthermore, physicians’ role in orienting CAM use was found to be marginal as patients relied mainly on family and
media for their choice of CAM and were less likely to disclose CAM use to their treating physicians.
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Background
Recent years have witnessed important advances in the
management of breast cancer, including surgery (often
combined with radiation) and adjuvant drug treatment.
These advances led to an overall 5-year survival rate
reaching up to 80 % for non-metastatic cases [1]. Despite
such advances, patients, particularly in low and middle
income countries, are often faced with many challenges
including the high cost and poor availability of treatments,
as well as significant side effects associated with many
conventional treatment modalities [2]. Furthermore, a sig-
nificant proportion of these patients are diagnosed at an
advanced stage of the disease when conventional therapies
have limited benefit [3]. The dissatisfaction, skepticism,
and poor availability of conventional cancer treatments
were suggested to drive a considerable proportion of pa-
tients to seek and explore alternative modalities for the
treatment of their disease [4]. These modalities are known
as complementary and alternative medicine (CAM). Re-
cently, the quest for a better quality of life has emerged as
an additional driving force behind the use of CAM among
breast cancer patients [5, 6].
CAM, as defined by the National Center for Comple-
mentary and Integrative Health in the United States, is
“a group of diverse medical and health care systems,
practices, and products that are not presently considered
to be part of conventional medicine”. Accordingly, CAM
is divided into two categories; ‘natural products’ and
‘mind and body practices’ [7]. A few investigations docu-
mented a relatively high prevalence of CAM use among
cancer patients in general [8] and breast cancer patients
in particular [9–12]. A study including 11 countries in
Europe reported a 44.7 % prevalence of CAM use among
breast cancer patients [9]. More recent studies have
shown even higher rates of CAM use in this patient
population, ranging between 62.9 % in Germany [10],
81.9 % in Ontario, Canada [11] and 86.1 % in the United
States [12]. A review of studies examining the types of
CAM used by breast cancer patients reported that the
most common were herbs, special foods and vitamins
followed by spirituality such as prayer, meditation and
mental healing [5]. In fact, turning to God or a higher
spiritual power has been suggested to be one of the cop-
ing strategies of patients with life-threatening diseases
including breast cancer [13].
Though prevalent, the use of CAM among breast can-
cer patients may present significant challenges. Certain
CAM types may worsen the side effects of conventional
therapies and negatively influence the response to treat-
ment, thereby compromising its desired outcome [14, 15].
The use of some herbs, vitamins and antioxidants could
potentially reduce the efficacy of conventional treatment
(chemotherapy, radiotherapy and hormonal treatment)
[15, 16]. In addition to its influence on outcomes of
conventional treatments, CAM use has also been examined
in association with the quality of life (QOL). While some
studies indicated a better QOL among CAM users, the lit-
erature regarding this association is still inconclusive [17].
The Middle East and North Africa region (MENA) har-
bors one of the fastest growing markets of CAM products
in the world [18], yet little is known about the use of
CAM therapies among breast cancer patients in this re-
gion. The present study aimed at investigating CAM use
among breast cancer patients in Beirut, Lebanon. Specific
research questions were:
1) What is the prevalence of CAM use?
2) What are the socio-demographic and disease-related
correlates of CAM use?
3) What are the types of CAM used?
4) What are the characteristics of CAM use, including
factors influencing CAM choice, reasons for using
CAM, and rate of disclosure to treating physicians?
A secondary research question was whether CAM use
was associated with QOL in this patient population.
Methods
Study design and subjects
This study utilized a non-experimental ‘modified’ cross-
sectional survey design, whereby data collection took
place at two time points, three to four weeks apart. The
data collected at each time point was cross-sectional in
nature. The study was conducted between October 2013
and August 2014. Subjects were recruited from two
major health care facilities in Beirut: a philanthropic
general hospital and a private academic medical center.
The philanthropic hospital and the medical center are
both accredited by the Lebanese Ministry of Health and
attract a large proportion of the patient population in
Lebanon. The philanthropic general hospital generally
serves patients belonging to a lower socioeconomic class
as compared to the private academic medical center.
Ethical approval for this study was obtained from both
sites where the study took place; the private academic cen-
ter and the philanthropic hospital. At the academic med-
ical center, approval was obtained from the Institutional
Review Board (IRB), the division of the Social and
Behavioral Sciences, under the following protocol ID:
NUT FN.11. At the philanthropic hospital, the hospital’s
ethics committee approved the study protocol.
Based on sample size calculations, a sample of 190
patients was needed to estimate CAM use prevalence
among breast cancer patients, assuming a 95 % confi-
dence interval, a 5 % margin of error, and an assumed
prevalence of CAM use of 15 %. The latter prevalence
was based on the findings of a previous investigation
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on CAM use prevalence among leukemia patients in
Lebanon [19].
Inclusion/exclusion criteria
Inclusion criteria were: female sex, older than 18 years
of age, Lebanese nationality, conversant in either English
or Arabic, and diagnosed with breast cancer for at least
two months. The two-month duration allowed time for
patients to explore the different CAM modalities avail-
able [20]. Subjects were excluded if they were unable or
unwilling to give their consent to the study.
Data collection
Recruitment of breast cancer patients took place at the
waiting room in the clinics of the academic medical cen-
ter and the philanthropic hospital. To ensure a represen-
tative cross-sectional sample of patients from the two
recruitment sites, interviews were conducted on differ-
ent days of the week and at varying times of the day.
As indicated earlier in this section, data collection took
place at two separate time points. Through face-to-face
interviews at the recruitment site, study participants
completed a CAM-related questionnaire. Three to four
weeks later, QOL assessment was carried by telephone.
There were two main reasons for carrying out the QOL
assessment by telephone and separate from the face-to-
face interview at the hospital: First, research approvals
obtained from the two participating health care facilities
advised against long questionnaires, especially with cancer
patients, and required the research team to carry the QOL
questioning only for patients who, during the hospitals
face-to-face interview, consented to being contacted later
for future research. Second, the QOL questionnaire
included a few sensitive questions about sexuality and in-
timate relationships which were deemed more appropriate
to be asked over the phone as compared to face-to-face
interviews.
At the hospitals, trained research assistants approached
patients and obtained written consent from those agreeing
to participate. Patients were reassured that their answers
were confidential and would not be shared with their
health care providers. The signed consent forms were kept
separate from questionnaires in order to ensure that none
of the consent forms can be linked to their corresponding
questionnaires, thus protecting the anonymity of each
patient. Completed questionnaires were kept in locked cab-
inets and electronic data was saved in password-protected
computers with access available only to the investigators.
During the face-to-face interviews at the hospitals, pa-
tients completed the CAM questionnaire used in this
study and which consisted of three sections; the first sec-
tion included questions assessing socio-demographic and
lifestyle characteristics of the study participants such as
age, marital status, educational level, employment status,
and health insurance. The second section included ques-
tions specific to breast cancer and general health, such as
the duration of breast cancer, history of breast cancer in
the family, and stage of the disease (early, locally ad-
vanced, or metastatic). The last section of the question-
naire included questions assessing the frequency and
types of CAM used as well as the characteristics of the
CAM use such as the factors influencing CAM choice,
reasons for using CAM, rate of disclosure to treating phy-
sicians, and CAM-related side effects. CAM use was de-
fined as using CAM at least once after breast cancer
diagnosis. The types of CAM used were assessed using
the following question: ‘What type of CAM product have
you used?’ Patients were given seven choices to answer
this question (more than one choice could be indicated
whenever applicable). The choices were: vitamins and
minerals; dietary supplements; special foods; herbal rem-
edies/herbal preparations; spiritual healing; folk medicine
(bloodletting/cupping); and ‘other’ (specify). These choices
for the types of CAM included in this question were based
on prevalent CAM modalities reported in other investiga-
tions of CAM use in Lebanon [19, 21–23]. The content
validity of the questionnaire was confirmed by a panel of
experts consisting of an oncologist, nutrition epidemiolo-
gist and health policy expert. The questionnaire was ori-
ginally written in English and then translated to Arabic by
a professional translator. The translated Arabic version was
back-translated by another professional translator to en-
sure the parallel-form reliability of the questionnaire. The
original and the back-translated versions were reviewed for
consistency in meaning by two bilingual experts. A copy of
this questionnaire is found as Additional file 1.
Three to four weeks following the face-to-face inter-
views, the QOL assessment was carried out via tele-
phone using a second questionnaire: the Functional
Assessment of Cancer Therapy-Breast Symptom Index
(FACT-B) questionnaire, the Arabic version (Additional
file 2). FACT-B comprised of 37 items which measure
multidimensional QOL in patients with breast cancer. It
includes five subscales (Physical Well-Being (PWB), So-
cial Well-Being (SWB), Emotional Well-Being (EWB),
Functional Well-Being (FWB), and Breast Cancer Scale
(BCS)). The face validity of this version of the FACT-B
was recently examined among breast cancer patients in
Lebanon, and involved both quantitative (face-to-face in-
terviews with breast cancer patients (n = 33)) and quali-
tative assessments (two focus groups (4 women per
group)). Results indicated that for most of its subcat-
egories, the instrument adequately tackled the different
aspects that could possibly affect the QOL of women
with breast cancer. In both the qualitative and quantita-
tive assessments, the instrument was considered easy to
follow, short, simple, culturally appropriate and pertin-
ent to the women’s experience with the disease [24].
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For the QOL assessment, the research assistant was
extensively trained to collect data over the phone, deal
with sensitive topics, and address questions in a consid-
erate manner with no judgment, tone, or attitude.
Statistical analysis
The questionnaires were checked for completeness, and
responses were coded and entered into the Statistical
Package for the Social Sciences (SPSS) software version
21.0 for Windows. Frequencies and percentages as well
as means and standard deviations were used to describe
categorical and continuous variables, respectively. CAM
use, the main outcome in this study, was dichotomous
and defined as either using CAM at least once after
breast cancer diagnosis or not. Bivariate and multivariate
logistic regression analyses were applied to determine
the correlates of CAM use. Odds ratios and their respect-
ive 95 % confidence intervals were computed. The charac-
teristics of CAM use, including factors influencing CAM
choice, reasons for using CAM, and rate of disclosure to
treating physicians, were presented as frequencies and
proportions [n (%)]. The FACT-B QOL total score and the
scores on each of its five subscales were calculated as
means and standard deviations. The difference in QOL
scores between CAM users and non-users was assessed
using an independent sample t-test. A p-value of 0.05 was
used to determine statistical significance.
Results
Prevalence of CAM use
Out of the 190 breast cancer patients invited to partici-
pate, 180 completed the questionnaire (response rate:
94.7 %). Out of the 180 patients surveyed, 73 reported
using a form of CAM after diagnosis with the disease
(prevalence of CAM use 40.6 %, 95 % CI: 35 %-48 %).
Socio-demographic and disease-related correlates
Table 1 displays the various characteristics of the study
population and their association with CAM use. The pa-
tients’ mean age in this study was 53.78 ± 9.93 years.
Around two-thirds of study participants were recruited
from the academic medical center reflecting the propor-
tion of the breast cancer patients seen at this center as
compared to the philanthropic hospital. Using bi-variate
logistic regression, factors significantly associated with
CAM use included age, recruitment site, marital status,
monthly income and state of breast cancer. The results
of the multivariate logistic regression model used to
examine the correlates of CAM use in the study popu-
lation are presented in Table 2. After adjustment, CAM
use was found to decrease significantly with age (OR:
0.96, CI: 0.92-0.99). Also patients attending the philan-
thropic hospital had lower odds of using CAM as com-
pared to those attending the private academic medical
center (OR: 0.13, CI: 0.05-0.35). Finally, reporting an
advanced stage of breast cancer, as opposed to an early
stage of the disease, was associated with a greater odd
of CAM use (OR: 4.20, CI: 1.65-10.69).
Types of CAM used
The various types of CAM used by the study population
are illustrated in Fig. 1. The most commonly used CAM
was ‘special food’, followed by ‘herbal teas’, ‘diet supple-
ments’, ‘spiritual healing’, ‘vitamins and minerals supple-
ments’, and ‘folk medicine’. Among the ‘special foods’
reported were honey, black seed, camel milk, soy, pom-
egranate, and ginger. ‘Herbal tea’ consisted mainly of
‘Zhourat’ (a special mix of locally produced herbal infu-
sions) and green tea. Common ‘Diet supplements’ reported
were prebiotic and graviola pills. ‘Spiritual healing’ was in
the form of religion-specific practices such as saying
prayers, lighting candles, pledging specific vows, consuming
foods deemed holy such as ‘Zamzam water’ (a type of holy
water for Muslims, brought from Mecca), and fasting
(abstinence from any food or drink from dawn to sunset).
Multi-vitamins as well as iron pills were the main ‘vitamins
and minerals supplements’ reported. As for ‘folk medicine,
it mainly consisted of bloodletting and cupping (Fig. 1).
Characteristics of CAM use (including factors influencing
CAM choice, reasons for using CAM, and rate of
disclosure to treating physicians)
Table 3 describes the characteristics of CAM use
among study participants. When asked about the
main influence of their CAM choice, the majority of
patients reported either media or family beliefs with
less than one in ten patients indicating a heath care
practitioner, a health food shop salesman or an alter-
native medicine therapist. The most commonly cited
reason for using CAM was “belief in advantages of
CAM”, followed by “managing cancer complications
and slowing its progression”. When participants were
asked to assess the usefulness of CAM, only 5 pa-
tients described the CAM they have used as “not use-
ful at all”, and 7 patients reported experiencing side
effects due to CAM use. The majority of CAM users
indicated that they intend to use CAM again. The
main reason for not using CAM among non-users
was ‘lack of belief in the benefits of CAM’.
The rate of CAM use disclosure to physicians and the
reaction of the physicians are described in Fig. 2. Only
one in four patients chose to report their CAM use to
their physician. Upon disclosure, the reaction of the
physician was mainly discouraging, with only 20 % of pa-
tients reporting an encouraging reaction from their
treating physician.
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Association between CAM use and QOL
FACT-B was administered to all study participants who
consented in their face-to-face interviews at the hospitals
to be re-contacted for research and provided their phone
numbers (n = 83). Of those, 7 participants were not
reachable, though the attempted calls took place at dif-
ferent days of the week and varying times during the
day. Six additional patients refused to participate. The
final number of participants who completed the assess-
ment of the QOL survey was 70 (response rate: 85.4 %).
The total FACT-B score as well as the scores for the
various subscales (PWB, SWB, EWB, FWB, and BCS)
were lower among CAM users as compared to non-
users, though not significant. (data not shown).
Table 1 Association of socio-demographic and disease-related characteristics with CAM use in the study population (n = 180)
Characteristics Overall CAM users CAM non-users OR (95 % CI)a
n = 180 n = 73 n = 107
Age (years) 53.78 ± 9.93 50.78 ± 10 55.64 ± 9.43 0.95 (0.92-0.98)
Recruitment site
Private academic medical center 116 (64.4) 64 (87.7) 52 (48.6) 1
Philanthropic general hospital 64 (35.6) 9 (12.3) 55 (51.4) 0.13 (0.06-0.29)
Marital status
Single 35 (19.4) 8 (11) 27 (25.2) 1
Married 145 (80.6) 65 (89) 80 (74.8) 2.74 (1.17-6.44)
Educational level
High school or less 56 (31.1) 18 (24.7) 38 (35.5) 1
University degree 124 (68.9) 55 (75.3) 69 (64.5) 1.68 (0.87-3.27)
Employment status
Unemployed 128 (71.1) 51 (69.9) 77 (72) 1
Employed 52 (28.9) 22 (30.1) 30 (28) 0.90 (0.47-1.74)
Type of health insurance
Private 44 (24.4) 22 (30.1) 22 (20.6) 1
Public 136 (75.6) 51 (69.9) 85 (79.4) 0.60 (0.30-1.19)
Monthly incomeb
<500$ 36 (20.1) 9 (12.3) 27 (25.5) 1
500-1000$ 74 (41.1) 33 (45.2) 41 (38.7) 2.42 (0.99-5.84)
>1000$ 69 (38.5) 31 (42.5) 38 (35.8) 2.45 (1.00-5.97)
Duration of breast cancer
<1 year 71 (39.4) 32 (43.8) 39 (36.4) 1
1-5 years 66 (36.7) 24 (32.9) 42 (39.3) 0.70 (0.35-1.38)
>5 years 43 (23.9) 17 (23.3) 26 (24.3) 0.80 (0.37-1.72)
Family history of breast cancer
No 105 (58.3) 43 (58.9) 62 (57.9) 1
Yes 75 (41.7) 30 (41.1) 45 (42.1) 1.04 (0.579-1.90)
State of breast cancer
Early stage 99 (55) 32 (43.8) 67 (62.6) 1
Locally advanced 44 (24.4) 21 (28.8) 23 (21.5) 1.91 (0.93-3.95)
Metastatic 37 (20.6) 20 (27.4) 17 (15.9) 2.46 (1.14-5.33)
Adhere to doctor’s recommendations
No 12 (6.7) 6 (8.2) 6 (5.6) 1
Yes 168 (93.3) 67 (91.8) 101 (94.4) 1.51 (0.47-4.87)
aResults in bold are significant at p < 0.05
bThe symbol ‘$’ in this table refers to U.S. dollars
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Discussion
Prevalence of CAM use
In this cross-sectional study, 180 breast cancer patients
were surveyed about their use and perception of CAM.
The prevalence of CAM use found in this study (40 %)
is comparable in magnitude to the overall estimate
reported by Molassiotis et al. in 11 countries of Europe
(44.7 %) [9], yet it is lower than reports from Brazil,
Malaysia, Canada and The United States of America
[11, 12, 25, 26]. The variations in prevalence of CAM
use by geographic region could be in part explained by
differences in socio-cultural perceptions of CAM use,
disparities in the availability and access to conventional
medicine, differences in study designs and definitions
of CAM use in various studies [27].
The prevalent CAM use among breast cancer patients
reported in this study could be attributed to the eager-
ness of these patients to explore other treatment modal-
ities in their attempt to improve chances of cure of their
disease, reduce side effect and improve their quality of
life [4–6]. Furthermore, the culture in Lebanon encour-
ages the use of complementary therapies. Many Lebanese
families still include in their repertoire of medicinal use
many plant species even though very few have had their
medicinal properties investigated [22].
Socio-demographic and disease-related correlates
Similar to previous studies, in this study, older patients
and those belonging to a lower socioeconomic status
were less likely to use CAM, while patients with an ad-
vanced stage of the disease had higher odds of using
CAM [5, 26, 28, 29]. Older breast cancer patients tend
to be less distressed and anxious about their diagnosis
and are, therefore, less keen to seek complementary
therapies compared to younger patients [28]. The in-
verse association between socioeconomic status and
CAM use observed in this study could be a reflection of
the fact that, in Lebanon, CAM products and therapies
are paid out of pocket and are not covered by medical
insurance policies [30].
The association between CAM use and an advanced
stage of the cancer found in this study underscores the
fact that these patients tend to look for additional ther-
apies beyond conventional medicine to lessen the bur-
den of their illness [4–6].
Table 2 Multivariate logistic regression for correlates of CAM
use in the study population (n = 180)
Characteristic OR (95 % CI)a
Age (years) 0.96 (0.92-0.99)
Recruitment site
Private academic medical center 1





High school or less 1
University degree 0.53 (0.16-1.73)






> 1000$ 0.45 (0.13-1.53)
Family history of breast cancer
No 1
Yes 0.94 (0.46-1.91)
State of breast cancer
Early stage 1
Locally advanced 4.20 (1.65-10.69)
Metastatic 1.86 (0.79-4.40)
aResults in bold are significant at p < 0.05





Did not disclose 






Disclosed CAM use 
to the physician
Fig. 1 Distribution of the various types of CAM used in the study population (n = 73)
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Types of CAM used
In this study, regarding the types of CAM, and in con-
gruence with earlier reports, special foods, herbal teas,
and dietary supplements were the most commonly used
types of CAM [27, 31]. The high prevalence of use of
these CAM types in this study can be explained by the
fact that Lebanese and Arab herbalists have transmitted
the ancestral knowledge of a region earlier referred to as
Bilad al Sham – the Levant [32]. This region was
endowed with a rich floral and herbal diversity that con-
stituted a basis for health care, with very few species
imported from outside [33]. Furthermore, the prevalent
use of these therapies could be due to the common be-
lief that such therapies are natural and nontoxic, even
though such a belief is not based on scientific data. In
fact, although most of these therapies do indeed present
minimal health hazard, some of the estrogen-rich ther-
apies such as soy, used in this study, may not be recom-
mended, especially for estrogen-positive breast cancer
patients [34]. Furthermore, it is postulated that
antioxidant-rich food supplements such as the black
seed, pomegranate, and ginger supplements, also used
in this study, may interact with adjuvant endocrine
therapies [31].
In addition to aforementioned types of CAM, spiritual
healing was also used by a considerable proportion of
patients in this study, specifically “prayer” and “religious
vows”. A common denominator to all religions in Lebanon
is the incorporation of religious beliefs in daily practices,
with prayer being an integral part of the culture [23].
Characteristics of CAM use
In addition to prevalence and correlates, the characteris-
tics of CAM use were also investigated in this study popu-
lation. An interesting finding was that the majority of
patients using CAM chose their therapy based on input
from the media, personal or family beliefs, and not based
on the informed recommendation of a health professional.
This reliance on media and family and friends is a com-
mon feature of CAM use in the country, as earlier in-
vestigations about CAM use among various Lebanese
patients’ populations, including Type 2 Diabetes Mellitus,
infertility as well as pediatric leukemia, showed similar
Table 3 Prevalence and characteristics of CAM use in the study
population (n = 180)
Prevalence of CAM use n (%)
Used CAM since diagnosis
No 107(59.4)
Yes 73(40.6)
CAM related characteristics among CAM users (n = 73)
CAM choicea
Media 20 (27.4)
Family beliefs 20 (27.4)
Personal choice 18 (24.7)
Friends 8 (11.0)
Health care practitioner 3 (4.1)
Healthy food shop salesman 2 (2.7)
Alternative medicine therapist 2 (2.7)
Reasons of CAM usea
Belief in advantages of CAM 67 (91.2)
Managing cancer complications and slowing
its progression
56 (76.7)
Reduce side effects of conventional therapy 25 (34.2)
To feel more control over health 23 (31.5)
Family tradition/culture 22 (30.1)
Strengthen immunity 18 (24.6)
Provides energy 11 (15.1)
Provides hope/prayer 10 (13.7)
Relief from sorcery and spell 5 (6.6)
Disappointment from conventional therapy 3 (4.1)
Curiosity 3 (4.1)
How do you assess the usefulness of CAM
Not at all 5 (6.8)
Some 43 (58.9)
A lot, very satisfied 22 (30.1)
You can’t tell 3 (4.1)
Side effects from CAM
No 65 (90.3)
Yes 7 (9.7)




CAM related characteristics among non-users (n = 107)
Reasons for not using CAMa
Lack of belief in the benefits of CAM 36 (33.6)
Afraid of side effect 30 (28.0)
Table 3 Prevalence and characteristics of CAM use in the study
population (n = 180) (Continued)
The doctor didn’t prescribe CAM 21 (19.6)
Never heard of CAM 11 (10.3)
Additional burden 9 (8.4)
Would you consider using CAM in the future
No 91 (85.8)
Yes 15 (14.2)
aMore than one answer was applicable
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results [19, 21, 23]. This finding is also similar to the re-
sults of a German survey conducted on 170 breast cancer
patients, where the most prominent sources of informa-
tion for CAM choice were outside the medical system and
included families and friends (49 %) and media (39 %)
[10]. The observed marginal role physicians play in pa-
tients’ choice of the CAM is further underscored by the
fact that the majority of patients in this study did not dis-
close CAM use to their physicians. The low rate of dis-
closure to physicians is common across studies [35]. A
review of the characteristics of CAM use among breast
cancer patients indicated that almost 50 % of these pa-
tients do not disclose CAM use to their health care pro-
vider [5]. This could be attributed to several reasons: First,
the general negative attitude of health care providers to
CAM products and practices (also shown in this study)
may deter patients from sharing information about their
use of CAM; second, the patients’ concern about losing
their physicians’ trust if they disclose other therapies they
are using; third, the common belief that CAM products
are harmless and they are simple vitamins or immune
stimulants that alleviate the burden of the disease without
interfering with standard therapies.
Limitations
A few shortcomings in this study are worth mentioning.
A selection bias might have jeopardized the representa-
tiveness of the sample population and the external valid-
ity of the results. However, it is important to note that
the selection of two medical centers, a major academic
medical center and a philanthropic general hospital, en-
hanced the representation of various socio-economic
groups. Although patients were asked to report their
habits and opinions and were assured of the confidenti-
ality and privacy of their responses, it cannot be ascer-
tained that patients did not experience the social
desirability bias, potentially altering their answers to sat-
isfy their health care providers.
The value of a validated tool to assess CAM use (with stat-
istical estimates of validity and reliability) is acknowledged,
however no such tool exists in Lebanon. It is worth noting
that the lack of association observed between CAM use
and QOL could be due to the small sample number of pa-
tients completing the QOL questionnaire. Such a small
size could have resulted from splitting the QOL data col-
lection from the main interview at the hospitals where
CAM data was collected. Future larger-scale studies are
needed to elucidate the effect of CAM use on the QOL of
breast cancer patients in Lebanon.
Conclusions
In summary, this study confirms that the use of CAM is
prevalent among Lebanese breast cancer patients, with spe-
cial foods, herbal teas, and dietary supplements being most
commonly used. While CAM use was found to be nega-
tively associated with older age and belonging to a lower so-
cioeconomic class, it was positively associated with an
advanced stage of the cancer. Physicians’ role in orienting
CAM use in this patient population was marginal as pa-
tients relied mainly on family and the media for the choice
of CAM and were less likely to disclose CAM use to their
treating physicians. The use of CAM had no clear influ-
ence on a patient’s quality of life. The prevalent use of
CAM modalities among Lebanese breast cancer patients,
coupled with poor CAM use disclosure to physicians,
could potentially jeopardize the health and wellbeing of
patients. Physicians are recommended to adopt a pro-
active attitude to initiate discussion of CAM use with their
patients, always respecting the patients’ decision-making
power.
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